Clinical Trials

15 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × 90 days × Clear all
NCT06761677 2026-02-05

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

SymBio Pharmaceuticals

Phase 1/2 Suspended
43 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Epstein-Barr Virus Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07358910 2026-01-22

RACSMEI

Institut Pasteur du Cambodge

Recruiting
10,000 enrolled
Classical hematology

Zika Virus Infection, Vaccine-Preventable Diseases, Vector Borne Diseases, Severe Fever with Thrombocytopenia Syndrome, Adenoviridae Infections, Arenaviridae Infections, Brucellosis, Bunyaviridae Infections, Chickenpox, Chlamydia Infections, Communicable Diseases, Dengue, Elephantiasis, Filarial, Encephalitis, Japanese, Encephalitis, Tick-Borne, Enterovirus Infections, Giardiasis, Hepatitis A, Leishmaniasis, Leptospirosis, Malaria, Measles, Melioidosis, Meningitis, Mumps, Mycoplasma Infections, Parvoviridae Infections, Q Fever, Rift Valley Fever, Rotavirus Infections, Rubella, Schistosomiasis, Tetanus, Trichuriasis, Whooping Cough, Yellow Fever, Zoonoses, Hepatitis E, Caliciviridae Infections, Hantavirus Infections, Epstein-Barr Virus Infections, Henipavirus Infections, Neglected Diseases, Chikungunya Fever